Current Psychopharmacology
Volume 9, 3 Issues, 2020
ISSN: 2211-5579 (Online)
ISSN: 2211-5560 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal
ISSN: 2211-5579 (Online)
ISSN: 2211-5560 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Aims & Scope
Current Psychopharmacology publishes peer-reviewed expert full-length/mini reviews, original research articles and single topic guest edited issues on all aspects of pre-clinical and clinical research in psychopharmacology. The journal aims to be the leading forum for expert review articles in the field. The journal also accepts high-level original research articles on outstanding topics of preclinical and clinical psychopharmacology.
Current Psychopharmacology
,Volume 9
-Number 2
Biography Open Access
Meet Our Associate Editorial Board Member
, 9(2): 79Karthick Subramanian
DOI: 10.2174/221155600902200703094839
Meet Our Associate Editorial Board Member
Editorial Open Access
Psychopharmacology in Student Health (College and Graduate): Substance Use Disorders and Psychiatry
, 9(2): 80 - 81Mark S. Gold and Jessica A. Gold
DOI: 10.2174/221155600902200703100708
Psychopharmacology in Student Health (College and Graduate): Substance Use Disorders and Psychiatry
Review Article
Anxiety Disorders’ Effect on College and University Students’ Mental Health: A Common and Growing Concern
, 9(2): 82 - 90Matthew J. Pesko*
DOI: 10.2174/2211556009999200408105509
Anxiety Disorders’ Effect on College and University Students’ Mental Health: A Common and Growing Concern
Review Article
Eating Disorders on College Campuses in the United States: Current Insight on Screening, Prevention, and Treatment
, 9(2): 91 - 102Anne C. Grammer*, Ellen E. Fitzsimmons-Craft, Olivia Laing, Bianca De Pietro and Denise E. Wilfley
DOI: 10.2174/2211556009999200416153022
Eating Disorders on College Campuses in the United States: Current Insight on Screening, Prevention, and Treatment
Review Article
Marijuana Use in Young Adults: What Do We Know?
, 9(2): 103 - 114Michael Wenzinger* and Fayola Fears
DOI: 10.2174/2211556009999200414153806
Marijuana Use in Young Adults: What Do We Know?
Review Article
Hallucinogen Use in College Students: Current Trends and Consequences of Use
, 9(2): 115 - 127Lena S. Jia* and Jessica A. Gold
DOI: 10.2174/2211556009666200311140404
Hallucinogen Use in College Students: Current Trends and Consequences of Use
Systematic Review Article
Social Media Use in College-age Youth: A Comprehensive Review and a Call to Action
, 9(2): 128 - 143Hilary Holmes*, Alba E. Lara and Gregory S. Brown
DOI: 10.2174/2211556009999200408112951
Social Media Use in College-age Youth: A Comprehensive Review and a Call to Action
General Review Article Open Access
Role of Neurochemicals in Schizophrenia
, 9(2): 144 - 161Sher Singh, Deepa Khanna* and Sanjeev Kalra
DOI: 10.2174/2211556009666200401150756
Role of Neurochemicals in Schizophrenia
Current Psychopharmacology, Volume 9 (2020) - Number 3
This issue is in progress but contains articles that are final and fully citable.
Biography Open Access
Meet Our Editorial Board Member
Perspective
Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-Induced Hyperalgesia
, 9(3): 164 - 184Raymond Brewer, Kenneth Blum*, Abdalla Bowirrat, Edward J. Modestino, David Baron, Rajendra D. Badgaiyan, Mark Moran, Brent Boyett and Mark S. Gold
DOI: 10.2174/2211556009999200628093231
Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-Induced Hyperalgesia
Review Article
Overview on Phyto-based Treatment for Anxiety
, 9(3): 185 - 210Jyoti Alambayan and Vandana Garg*
DOI: 10.2174/2211556009999200723122833
Overview on Phyto-based Treatment for Anxiety
Research Article
Improvement of Negative Symptoms in Schizophrenia: A Doubleblind Clinical Trial by Escitalopram in Male Patients
, 9(3): 211 - 217Saeed S. Shafti*
DOI: 10.2174/2211556009999200513074605
Improvement of Negative Symptoms in Schizophrenia: A Doubleblind Clinical Trial by Escitalopram in Male Patients
Research Article
A Study of Metabolic Syndrome in Patients on Risperidone
, 9(3): 218 - 227Ajay Thangraj, Nimesh G. Desai and Vijender Singh*
DOI: 10.2174/2211556009666200316143613
A Study of Metabolic Syndrome in Patients on Risperidone
Research Article
Medication-Precipitated Seizure in Psychiatric Patients: Typical vs. Atypical Antipsychotics
, 9(3): 228 - 233Saeed S. Shafti*
DOI: 10.2174/2211556009999200606221247
Medication-Precipitated Seizure in Psychiatric Patients: Typical vs. Atypical Antipsychotics
Research Article
Method Validation for the Determination of Carbamazepine in Spiked-saliva Using HPLC-UV for Therapeutic Drug Monitoring Application
, 9(3): 234 - 241Ari Wibowo, Vitarani D.A. Ningrum* and Rahma N. Ilhamy
DOI: 10.2174/2211556009999200727191226
Method Validation for the Determination of Carbamazepine in Spiked-saliva Using HPLC-UV for Therapeutic Drug Monitoring Application
Acknowledgement Open Access
Acknowledgement to Reviewers
Articles Ahead of Print
Current Neuropharmacological Interventions in Autism: Potential Drug Targets from Pre-clinical and Clinical Findings
Ramit Sharma, Aarti Tiwari, Saloni Rahi and Sidharth Mehan*
DOI: 10.2174/1389203721999200820165117
View Abstract
The Plastic and Functional Changes in Hippocampal Neurons During Pregnancy, Delivery and Postpartum Are Reversed by Offspring Deprivation
Maria C. Mostallino*, Pietro P. Secci, Elena Paci, Maria L. Mura, Elisabetta Maciocco, Enrico Sanna and Giovanni Biggio
DOI: 10.2174/2211556009999200819102313
View Abstract
Assessing Collegiate Recovery Programs and the Challenges of Campus Binge Drinking
Andrew Downing* and Jessica Hulsey Nickel
DOI: 10.2174/2211556009999200817134231
View Abstract
The Impact and Sequelae of Sexual Victimization of Graduate and Professional Students
Philip Hemphill* and Margaret Reynolds
DOI: 10.2174/2211556009999200730115827
View Abstract
Early Psychosis: Diagnosis and Treatment
Nataly S. Beck, Melanie L. Lean, Kate V. Hardy and Jacob S. Ballon*
DOI: 10.2174/2211556009999200723123322
View Abstract
A Comparative Study between Lithium and Extended-release Carbamazepine in Acute Mania: A Double-blind Clinical Trial
Saeed Shoja Shafti* and Hamid Kaviani
DOI: 10.2174/2211556009999200616130803
View Abstract
Transitioning from Child and Adolescent to Adult Psychiatric Care: Improving Outcomes After University Matriculation
Giuseppe D’ Amelio* and Jessica A. Gold
DOI: 10.2174/2211556009999200616131458
View Abstract
ADHD in College Students - A Guide for Clinicians and Administrators
Aaron Winkler, Bettina Bohle-Frankel*, Leigh White, Gordon Strauss and Diane Gottlieb
DOI: 10.2174/2211556009999200616132427
View Abstract
Combatting the Epidemic of E-cigarette Use and Vaping among Students and Transitional-Age Youth
Lisa Domenico, Christina E. DeRemer, Kathy L. Nichols, Christopher Campbell, Jacquelyn R. Moreau, Gail S. Childs and Lisa J. Merlo*
DOI: 10.2174/2211556009999200613224100
View Abstract
Abstracts Ahead of Print
There are currently no Abstracts Ahead of Print available for this journal.
Published Contents
- Current Psychopharmacology, Volume 9, 2020
- Current Psychopharmacology, Volume 8, 2019
- Current Psychopharmacology, Volume 7, 2018
- Current Psychopharmacology, Volume 6, 2017
- Current Psychopharmacology, Volume 5, 2016
- Current Psychopharmacology, Volume 4, 2015
- Current Psychopharmacology, Volume 3, 2014
- Current Psychopharmacology, Volume 2, 2013
- Current Psychopharmacology, Volume 1, 2012
Editor's Choice
Role of Neurochemicals in Schizophrenia
, 2020; 9(2): 144 - 161Sher Singh, Deepa Khanna* and Sanjeev Kalra
DOI: 10.2174/2211556009666200401150756
In Search of Reward Deficiency Syndrome (RDS)-Free Controls: The “Holy Grail” in Genetic Addiction Risk Testing
, 2020; 9(1): 7 - 21Kenneth Blum*, David Baron, Lisa Lott, Jessica V. Ponce, David Siwicki, Brent Boyett, Bruce Steinberg, Edward J. Modestino, Lyle Fried, Mary Hauser, Thomas Simpatico, Bill W. Downs, Thomas McLaughlin, Raju Hajela and Rajendra D. Badgaiyan
DOI: 10.2174/2211556008666191111103152
Rapid Anti-Depressant Relief by Ketamine: Exploring A Complex Mechanism of Action
, 2019; 8(2): 99 - 112Kenneth Blum*, Todd C. Pappas, Bryan Clifton, David Baron, Margaret A. Madigan, Lisa Lott, Mark Moran, Cannon Clifton, Scott Worrich, Ervey Clarke, Brent Boyett, Abdalla Bowirrat and Mark S. Gold
DOI: 10.2174/2211556008666190827150018
Psychopharmacology for Patients with Parkinson’s Disease and Deep Brain Stimulation: Lessons Learned in an Academic Center
, 2019; 8(1): 41 - 54Andreea L. Seritan*, Peter Ureste, Tammy Duong and Jill L. Ostrem
DOI: 10.2174/2211556007666180328142953
Mechanistic Description of Natural Herbs in the Treatment of Dementia: A Systematic Review
, 2018; 7(2): 149 - 164Bapi Gorain*, Hira Choudhury, Manisha Pandey, Hasbi Laili Bt Mohd Zaki, Nuurul Izzati Bt Bakar, Nur Hanis Bt Hamdhan, Nor Aniza Bt Musa, Nurul Fadhilah Bt Mustafa, Jaya Sree Sangkari, Nur Ain Athirah Bt Azmi, Lui Park Yeang and Prashant Kesharwani
DOI: 10.2174/2211556007666180420124544
Management of Adverse Effects from Atypical Antipsychotics
, 2018; 7(1): 23 - 35Ahsan Nazeer* and Joseph L. Calles
DOI: 10.2174/2211556007666180220162945
Meta-analysis of Native Studies as Regards the Effectiveness of Antidepressants on Deficit Syndrome of Schizophrenia: A Systematic Review
, 2017; 6(2): 148 - 157Saeed S. Shafti*
DOI: 10.2174/2211556006666170419161746
Psychiatric Polypharmacy, Etiology and Potential Consequences
, 2017; 6(1): 12 - 26Sonali Sarkar*
DOI: 10.2174/2211556005666160916124719
A Review of Monoaminergic Neuropsychopharmacology in Zebrafish, 6 Years Later: Towards Paradoxes and their Solution
, 2016; 5(2): 96 - 138Caio Maximino, Bruna P. Costa and Monica G. Lima
DOI: 10.2174/2211556005666160527105104
A Comparison Between Quetiapine and Aripiprazole for Treatment of Schizophrenia: A Double Blind Contrast
, 2016; 5(1): 13 - 19Saeed S. Shafti and Hamid Kaviani
DOI: 10.2174/2211556005666160301231207
Open Access Articles
Role of Neurochemicals in Schizophrenia
, 2020; 9(2): 144 - 161Sher Singh, Deepa Khanna* and Sanjeev Kalra
In Search of Reward Deficiency Syndrome (RDS)-Free Controls: The “Holy Grail” in Genetic Addiction Risk Testing
, 2020; 9(1): 7 - 21Kenneth Blum*, David Baron, Lisa Lott, Jessica V. Ponce, David Siwicki, Brent Boyett, Bruce Steinberg, Edward J. Modestino, Lyle Fried, Mary Hauser, Thomas Simpatico, Bill W. Downs, Thomas McLaughlin, Raju Hajela and Rajendra D. Badgaiyan
Oxidative Stress Targeting Amyloid Beta Accumulation and Clearance in Alzheimer’s Disease: Insight into Pathological Mechanisms and Therapeutic Strategies
, 2020; 9(1): 22 - 42Sunpreet Kaur, Puneet Kumar and Shamsher Singh*
The Impact and Sequelae of Sexual Victimization of Graduate and Professional Students
, 2020; 9: 1 - 10 (E-Pub Ahead of Print)Philip Hemphill* and Margaret Reynolds
Sudden Death Associated with Complex Treatment of Acute Mania: Case Report and Toxicological Findings
, 2019; 8(3): 238 - 243Martina Curto*, Luana Lionetto, Maria Chiara David, Aniello Maiese, Stefano Ferracuti, Maurizio Simmaco and Ross J. Baldessarini
Evaluation of Antipsychotic Activity of Ethanolic Extract of Dhatryadi Ghrita on Wistar Rats
, 2019; 8(3): 213 - 237Rashmi S. Pal* and Amrita Mishra
Neuroleptic Malignant Syndrome: A Pilot Study on Psychiatric Inpatients in Iran
, 2019; 8(3): 207 - 212Saeed S. Shafti*, Alireza Memarie, Masomeh Rezaie and Masomeh Hamidi
Psychotropic Medication Use among Traumatized Individuals with and without Psychiatric Histories
, 2019; 8(3): 194 - 206Alan R. King*, Sara K. Kuhn, Stephanie Brezinski, Michael Jowkar and Kourtney Smith
An Insight on the Association of Psychological Studies, Cognitive Sciences and Meditation in Treating Depression
, 2019; 8(3): 177 - 193Rashmi S. Pal*, Nikita Saraswat, Pranay Wal, Ankita Wal, Yogendra Pal and Tamsheel F. Roohi
GABRB2 in Neuropsychiatric Disorders: Genetic Associations and Functional Evidences
, 2019; 8(3): 166 - 176Shui Y. Tsang, Ata Ullah and Hong Xue*
Rapid Anti-Depressant Relief by Ketamine: Exploring A Complex Mechanism of Action
, 2019; 8(2): 99 - 112Kenneth Blum*, Todd C. Pappas, Bryan Clifton, David Baron, Margaret A. Madigan, Lisa Lott, Mark Moran, Cannon Clifton, Scott Worrich, Ervey Clarke, Brent Boyett, Abdalla Bowirrat and Mark S. Gold
Neurosteroids and Affective Disorders in Women
, 2019; 8(2): 89 - 98Rodrigo Guiza-Zayas*, Mónica Flores-Ramos, Norma Bernal-Santamaría, María Fernanda Del-Pino Mijares and Marián Serna-García
Sertraline Associated with REM Sleep Behavior Disorder: A Case Report
, 2019; 8(2): 159 - 162Seyed Mostafa Mansouripour * and Dharmendra Kumar
Low-Dose Lithium for Long-Term Treatment of Clozapine- Induced Neutropenia: A Case Series
, 2019; 8(2): 155 - 158Muhammad R. Baig*
Evaluation of Second Generation Antipsychotics, as Augmentative Plan, in Treatment-Resistant Obsessive-Compulsive Disorder
, 2019; 8(2): 146 - 154Saeed S. Shafti* and Hamid Kaviani
Most Cited Articles
Pharmacological Manipulation of Shoaling Behavior in Zebrafish
, 2016; 5(2): 180-193.Soaleha Shams and Robert T. Gerlai
DOI: 10.2174/2211556005666160607094906
Odyssey of ‘Negative Symptoms’ of Schizophrenia: Rehabilitation vs Stigmatization
, 2015; 4(1): 40-51.Saeed Shoja Shafti
DOI: 10.2174/2211556004666150918193742
The Novel Tank Test: Handling Stress and the Context Specific Psychopharmacology of Anxiety
, 2016; 5(2): 169-179.Steven Tran and Robert T. Gerlai
DOI: 10.2174/2211556005666160519144414
Relevance of Test- and Subject-Related Factors on Inhibitory Avoidance (Performance) of Zebrafish for Psychopharmacology Studies
, 2016; 5(2): 152-168.Remy Manuel, Marnix Gorissen and Ruud van den Bos
DOI: 10.2174/2211556005666160526111427
A Review of Monoaminergic Neuropsychopharmacology in Zebrafish, 6 Years Later: Towards Paradoxes and their Solution
, 2016; 5(2): 96-138.Caio Maximino, Bruna P. Costa and Monica G. Lima
DOI: 10.2174/2211556005666160527105104
Zebrafish as an Animal Model to Study Epileptic Seizures and Epileptic Syndromes
, 2016; 5(2): 194-210.Ben H.M. Mussulini, Suelen Baggio, Luana Moro, Renato D. Dias, Maria E. Calcagnotto, Eduardo P. Rico and Diogo L. de Oliveira
DOI: 10.2174/2211556005666160615090734
Zebrafish Models to Study Fear and Anxiety
, 2016; 5(2): 139-151.Adam D. Collier and David J. Echevarria
DOI: 10.2174/2211556005666160608124610
Most Accessed Articles
Oxidative Stress Targeting Amyloid Beta Accumulation and Clearance in Alzheimer’s Disease: Insight into Pathological Mechanisms and Therapeutic Strategies
, 2020; 9(1): 22-42.Sunpreet Kaur, Puneet Kumar and Shamsher Singh*
DOI: 10.2174/2211556009666191231155927
Amelioration of Dementia and Antioxidant Activity of Holarrhena antidysenterica Bark in Mice
, 2020; 9(1): 43-57.Jasleen Kaur, Manish Kumar and Nitin Bansal*
DOI: 10.2174/2211556009666200129123134
In Search of Reward Deficiency Syndrome (RDS)-Free Controls: The “Holy Grail” in Genetic Addiction Risk Testing
, 2020; 9(1): 7-21.Kenneth Blum*, David Baron, Lisa Lott, Jessica V. Ponce, David Siwicki, Brent Boyett, Bruce Steinberg, Edward J. Modestino, Lyle Fried, Mary Hauser, Thomas Simpatico, Bill W. Downs, Thomas McLaughlin, Raju Hajela and Rajendra D. Badgaiyan
DOI: 10.2174/2211556008666191111103152
Dopamine Pharmacological Agents in Resistant-OCD
, 2012; 1(1): 44-46.Stefano Pallanti, Giacomo Grassi and Iuliia Burian
DOI: 10.2174/2211556011201010044
Evaluation of the Antidepressant Like Activity of Ethanolic Extract of Calendula officinalis using Rodent Models (Wistar Rat) of Depression
, 2020; 9(1): 58-67.Kaur Rajwinder, Rajmeet Singh*, Lalit, Kaur Jaswinder and Rajat
DOI: 10.2174/2211556009666200217122202
Pathological Gambling: Neuropsychopharmacology and Treatment
, 2012; 1(1): 67-85.Scott A. Bullock and Marc N. Potenza
DOI: 10.2174/2211556011201010067
Nitrous Oxide-induced Impairment of Spatial Working Memory Requires Activation of GABAergic Pathways
, 2020; 9(1): 68-78.Dimitris E. Emmanouil*, Evan D. Klein, Katherine Chen, Abigail L. Brewer, Yangmiao Zhang and Raymond M. Quock
DOI: 10.2174/2211556009666200217121518
Polyunsaturated Fatty Acids and their Related Enzymes in Postmortem Brain Tissues of Patients with Psychiatric Disorders
, 2013; 2(1): 66-72.Kei Hamazaki, Tomohito Hamazaki and Hidekuni Inadera
DOI: 10.2174/2211556011302010066
Editor-in-Chief
Kenneth Blum
Western University of Health Sciences
Pomona, CA
(USA)
Biography
Western University of Health Sciences
Pomona, CA
Biography
Biography of Kenneth Blum
Dr. Blum serves as Chairman of Geneus Sciences LLC., His concept of Reward Deficiency Syndrome is
being embraced by world leaders in science and is part of the DSM –V, ASAM, Sage Encyclopedia of abnormal and clinical psychology 2017. Dr, Blum is credited with the DRD2 gene discovery and addictive diseases. He
serves as Editor-in-Chief in Journal of Reward Deficiency Syndrome (he coined) and Addiction Sciences
and Co-EIC of Journal of Neuroimaging in Psychiatry and Neurology (USG). He is currently serving on
fourteen other prestigious journal’s Editorial Boards. He has published over 450 articles, 16 books,
numerous patents and received many awards (Life-Time Achievements) for his seminal discoveries. He is
the founding President of United Scientific Group (USG).
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Psychopharmacology was launched in 2012. Dr. Kenneth Blum serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net